06.12.2016 22:02:00

Harwood Feffer LLP Announces Investigation of Diplomat Pharmacy, Inc.

NEW YORK, Dec. 6, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO), concerning whether the board has breached its fiduciary duties to shareholders.

On November 10, 2016, a class action was filed against Diplomat in the U.S. District Court for the District of Michigan, C.A. No. 5:16-cv-14005.  The class action complaint alleges that Diplomat and its representatives made failed to disclose that: (a) Diplomat lacked sufficient internal controls over its financial reporting; (b) it could not adequately calculate certain fees; (c) the hepatitis C segment was not performing as publicly stated; (d) the Company's 2016 guidance was unduly optimistic; and (e) the Company's public statements about its business, operations, and prospects, were inaccurate.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Diplomat shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email:  bsachsmichaels@hfesq.com
Website:   http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-diplomat-pharmacy-inc-300373963.html

SOURCE Harwood Feffer LLP

Nachrichten zu Diplomat Pharmacy Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Diplomat Pharmacy Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!